Roche Holding AG (OTCMKTS:RHHBY) Short Interest Update

Roche Holding AG (OTCMKTS:RHHBY) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 3,246,800 shares, an increase of 25.2% from the September 30th total of 2,593,100 shares. Based on an average daily trading volume, of 2,151,600 shares, the days-to-cover ratio is currently 1.5 days.

Roche Trading Down 1.0 %

OTCMKTS:RHHBY traded down $0.39 during mid-day trading on Wednesday, hitting $39.46. 831,027 shares of the company’s stock were exchanged, compared to its average volume of 2,155,573. The business has a fifty day moving average price of $39.84 and a 200 day moving average price of $36.50. Roche has a one year low of $29.20 and a one year high of $42.43.

Analyst Ratings Changes

Several research firms have weighed in on RHHBY. Bank of America upgraded shares of Roche from a “neutral” rating to a “buy” rating in a report on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold”.

Institutional Trading of Roche

Several hedge funds and other institutional investors have recently made changes to their positions in RHHBY. AlphaMark Advisors LLC purchased a new position in Roche in the first quarter worth about $34,000. GAMMA Investing LLC lifted its position in Roche by 61.5% in the 2nd quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock valued at $175,000 after acquiring an additional 1,919 shares in the last quarter. Archer Investment Corp boosted its stake in Roche by 10.6% during the 2nd quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after purchasing an additional 652 shares during the last quarter. Waldron Private Wealth LLC bought a new stake in shares of Roche in the 2nd quarter worth $263,000. Finally, Lee Danner & Bass Inc. bought a new position in shares of Roche during the second quarter valued at $327,000.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.